A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum
Clinical trial NCT02488902 · COMPLETED
Trial details
- NCT number
- NCT02488902
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-01
- Primary completion
- 1998-09-01
- Enrollment
- 521
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.